Strengthening Adherence to Antiretroviral-Based HIV Treatment and Prevention (R21)
ArchivedNational Institutes of Health
Description
This Funding Opportunity Announcement (FOA) encourages research to understand and promote adherence to antiretroviral (ARV) regimens for HIV treatment and prevention. Studies addressing pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) are the foci of this FOA. The overarching emphasis is on the development of feasible interventions to improve and sustain PrEP or ART adherence which could be rapidly implemented in clinical, community, and policy environments to improve HIV treatment and prevention outcomes.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedFeb 28, 2014
- ClosesJan 7, 2017
- Award ceiling$200,000
- CFDA93.242, 93.856
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro